Laurence M. Corash

Hematology
505 Parnassus Ave
San Francisco, CA 94143

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 56 publications

Pathogen Reduction of Transfused Blood Components-The End of the Beginning Rather than the Beginning of the End.

Pathogen Reduction of Transfused Blood Components-The End of the Beginning Rather than the Beginning of the End.

Journal: Pathogens (Basel, Switzerland)
Published: March 11, 2026

The need for dried plasma-Still a national issue: Where are we and recommendations.

The need for dried plasma-Still a national issue: Where are we and recommendations.

Journal: Transfusion
Published: February 23, 2026

A randomized, double-blind, controlled, parallel group study with amustaline/glutathione pathogen reduced red blood cells in regions at potential risk for Zika virus transfusion-transmitted infections (RedeS Study)-protocol for a phase 3 clinical trial.

A randomized, double-blind, controlled, parallel group study with amustaline/glutathione pathogen reduced red blood cells in regions at potential risk for Zika virus transfusion-transmitted infections (RedeS Study)-protocol for a phase 3 clinical trial.

Journal: Trials
Published: January 28, 2026

Safety and Efficacy of Amotosalen-Ultraviolet A Pathogen-Reduced Platelets Transfused to Neonates.

Safety and Efficacy of Amotosalen-Ultraviolet A Pathogen-Reduced Platelets Transfused to Neonates.

Journal: Transfusion medicine and hemotherapy : offizielles Organ der Deutschen Gesellschaft fur Transfusionsmedizin und Immunhamatologie
Published: January 21, 2026

Safety and tolerability of amustaline/glutathione pathogen-reduced red blood cells in neonatal rats.

Safety and tolerability of amustaline/glutathione pathogen-reduced red blood cells in neonatal rats.

Journal: Transfusion
Published: December 24, 2025

Pathogen-reduced plasma, cryoprecipitate reduced for therapeutic plasma exchange.

Pathogen-reduced plasma, cryoprecipitate reduced for therapeutic plasma exchange.

Journal: Transfusion
Published: November 03, 2025

Amustaline/glutathione pathogen-reduced red cell hemoglobin utilization in complex cardiac surgery: A post hoc analysis of the phase 3 ReCePI trial.

Amustaline/glutathione pathogen-reduced red cell hemoglobin utilization in complex cardiac surgery: A post hoc analysis of the phase 3 ReCePI trial.

Journal: Transfusion
Published: September 07, 2025

Retention of critical platelet hemostatic functions of amotosalen-UVA pathogen-reduced cryoprecipitated fibrinogen complex.

Retention of critical platelet hemostatic functions of amotosalen-UVA pathogen-reduced cryoprecipitated fibrinogen complex.

Journal: Transfusion
Published: February 04, 2025

A novel acridine flow cytometry marker to track post-transfusion amustaline/glutathione pathogen-reduced red blood cell survival in sickle cell disease patients.

A novel acridine flow cytometry marker to track post-transfusion amustaline/glutathione pathogen-reduced red blood cell survival in sickle cell disease patients.

Journal: Transfusion
Published: December 04, 2024

Characterizing the antibody response to amustaline/glutathione pathogen-reduced red blood cells.

Characterizing the antibody response to amustaline/glutathione pathogen-reduced red blood cells.

Journal: Transfusion
Published: July 31, 2024

Human leukocyte antigen alloimmunization in a randomized trial of amustaline/glutathione pathogen-reduced red cells in complex cardiac surgery patients.

Human leukocyte antigen alloimmunization in a randomized trial of amustaline/glutathione pathogen-reduced red cells in complex cardiac surgery patients.

Journal: Transfusion
Published: July 30, 2024

In vivo genotoxicity assessment of N-(-9 acridinyl)-b-alanine hydrochloride (S-300) using a validated Pig-a mutagenesis assay.

In vivo genotoxicity assessment of N-(-9 acridinyl)-b-alanine hydrochloride (S-300) using a validated Pig-a mutagenesis assay.

Journal: Transfusion
Published: February 15, 2024
Showing 1-12 of 56

Last Updated: 09/26/2026